An Open Letter to DeepIntent Clients and Partners on the IQVIA Acquisition (2nd and Final Update)
Keeping with my promise to keep you, our clients and partners, informed about our proposed acquisition by IQVIA, I write today to share a …
Keeping with my promise to keep you, our clients and partners, informed about our proposed acquisition by IQVIA, I write today to share a …
It’s no easy feat for healthcare marketers to achieve the optimal audience mix for their campaigns. They must carefully select audience segments that are …
With the rise of artificial intelligence and machine learning, new innovations in healthcare advertising seem to crop up every day. However, it can be …
As one of the most important events in our industry, Digital Pharma East is crucial for furthering the conversation around trends that will impact …
As you may know, DeepIntent entered into a definitive agreement to be acquired by IQVIA during the second half of 2022. I’ve committed to …
There’s a $14 billion opportunity at the intersection of healthcare, data, media, and artificial intelligence. And sitting at that intersection is convergent TV, which we …
There are more than 20,000 prescription drugs approved for marketing by the Food and Drug Administration (FDA). And yet, they all have one big …
In its true form, convergence refers to the shift from analog to digital, something that’s been happening for many years. By 2022, Leichtman Research …
Healthcare marketers are looking for deeper, more actionable insights to inform how their campaigns are performing. While clicks and impressions are useful digital metrics …